Smaller Robotic Platforms Could Reshape the Surgical Robots Market

The global surgical robots market was valued at USD 14.1 billion in 2025 and is projected to reach USD 45.6 billion by 2033, expanding from USD 17.2 billion in 2026 at a 14.9% CAGR from 2026 to 2033. North America dominated the market in 2025, accounting for 47.0% of global revenue.

Market growth is primarily driven by the increasing adoption of robotic-assisted minimally invasive surgery, rising demand for greater surgical precision, and the expanding use of advanced robotic instruments, visualization technologies, and accessories across hospitals and ambulatory surgical centers.

Surgical Robots Market Overview

The surgical robots market is experiencing rapid expansion as healthcare providers increasingly adopt robotic platforms for minimally invasive and complex surgical procedures. Advances in robotic instrumentation, surgical visualization, navigation, artificial intelligence, and procedure planning are broadening the clinical applications of surgical robots across multiple specialties.

According to Grand View Research, the global surgical robots market is expected to grow from USD 17.2 billion in 2026 to USD 45.6 billion by 2033, representing a 14.9% CAGR during the forecast period. North America remains the largest regional market, while Asia Pacific is expected to record the fastest growth through 2033.

Go Deeper! Ask Prism AI

about the Global surgical robots market. Get instant answers to questions related to market sizing, growth drivers & their impact, and more.

Key Surgical Robots Market Trends & Insights

  • By component: Surgical robotic accessories accounted for the largest market share, at approximately 53.6% in 2025.
  • By application: General surgery represented the leading application segment, accounting for 28.7% of the market in 2025.
  • By end use: Inpatient settings dominated the market, with a 72.0% revenue share in 2025.
  • By region: North America held the largest regional share, while Asia Pacific is projected to register the fastest CAGR during 2026–2033.
  • By country: The U.S. represented the largest country-level market in 2025.

Surgical Robots Market Regional Highlights

North America – Largest Regional Market
North America accounted for 47.0% of global surgical robots market revenue in 2025, supported by high adoption of robotic-assisted surgery, advanced healthcare infrastructure, strong hospital investment, and the presence of leading robotic surgery companies.

Asia Pacific – Fastest-Growing Region
Asia Pacific is expected to register the highest CAGR from 2026 to 2033. Increasing healthcare expenditure, expanding hospital infrastructure, rising surgical volumes, and growing adoption of advanced minimally invasive technologies are supporting market expansion across the region.

U.S. – Leading Country Market
The U.S. held the largest country-level share of the global surgical robots market in 2025, supported by the widespread adoption of robotic surgical platforms and continued investment in advanced surgical technologies.

Surgical Robots Market Size & Forecast

Market Indicator

Value

Market size, 2025

USD 14.1 billion

Market size, 2026

USD 17.2 billion

Projected market size, 2033

USD 45.6 billion

CAGR, 2026–2033

14.9%

Download a free sample report or claim your copy of this full market intelligence report

Surgical Robots Market Growth Drivers

  1. Expanding Adoption of Robotic-Assisted Minimally Invasive Surgery

The growing adoption of robotic-assisted minimally invasive surgery is a major factor driving the surgical robots market. Robotic platforms are increasingly being used across general surgery, urology, gynecology, orthopedics, thoracic surgery, cardiac surgery, and spine procedures.

Hospitals and surgical centers are adopting robotic systems to improve surgical precision, visualization, instrument control, surgeon ergonomics, and procedural consistency while supporting minimally invasive approaches that can contribute to faster patient recovery.

The expansion of robotic surgery is also supported by increasing procedure volumes and a growing installed base of robotic surgical systems. In 2025, Intuitive Surgical reported that procedures performed using its da Vinci systems increased 18% to more than 3.1 million globally, including 15% growth in the U.S. and 23% internationally. The company placed 1,721 da Vinci systems during the year and ended 2025 with more than 11,100 systems installed worldwide.

The da Vinci 5 platform also recorded significant early adoption, with more than 1,200 systems installed across the U.S., South Korea, Japan, and Europe and more than 270,000 procedures performed by the end of 2025.

These developments demonstrate the increasing integration of robotic-assisted surgery into mainstream clinical practice and the expanding role of surgical robots across multiple specialties.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

  1. Technological Advancements in Robotic Surgery Platforms

Rapid advances in surgical imaging, navigation, artificial intelligence-enabled planning, fluorescence imaging, robotic instrumentation, and real-time decision support are accelerating the development of next-generation surgical robots.

Modern robotic platforms are increasingly designed to provide enhanced intraoperative visualization, improved instrument control, greater procedural accuracy, and more efficient surgical workflows. These capabilities are particularly important for complex minimally invasive procedures that require high levels of precision.

Companies are also integrating advanced visualization technologies into robotic surgery platforms. For example, in February 2024, CMR Surgical launched vLimeLite, an integrated fluorescence imaging system designed to enhance intraoperative visualization using indocyanine green. The technology helps surgeons assess blood flow and tissue perfusion during procedures.

Similarly, in February 2026, Medtronic received U.S. FDA clearance for its Stealth AXiS surgical system for spine procedures. The system combines surgical planning, real-time navigation, and robotic assistance within an integrated platform designed for use in hospitals and ambulatory surgery centers.

Such innovations indicate a broader shift toward intelligent, connected, and data-driven robotic surgery platforms capable of supporting increasingly complex procedures and improving operating-room workflow efficiency.

The expanding clinical use of robotic platforms also reflects growing acceptance of robotic-assisted surgery. In January 2026, the American College of Surgeons reported that more than 12 million surgeries had been performed globally using da Vinci systems, underscoring the increasing role of robotic surgery in minimally invasive care.

Explore the full list of profiled companies operating in this market with recent strategic initiatives

Competitive Landscape

The surgical robots market includes established medical technology companies and emerging robotic surgery specialists competing through platform innovation, expanded clinical applications, advanced visualization, navigation capabilities, and strategic product development.

Key Surgical Robots Companies

The major companies profiled in the surgical robots market study include:

  • Medtronic
  • Intuitive Surgical
  • MicroPort Scientific
  • SS Innovations
  • Stryker
  • Johnson & Johnson
  • Asensus Surgical US, Inc. | Part of KARL STORZ
  • Distalmotion
  • CMR Surgical
  • Moon Surgical

Explore our dedicated business services:

U.S. Healthcare Facility Mapping & Intelligence Platform: Get facility-level intelligence to guide smarter decisions. Sign up Today

Comments

Post a Comment

Popular posts from this blog

DNA-encoded Library Market Supports Faster Lead Identification

The global   DNA-encoded library (DEL) market   was valued at USD 758.1 million in 2024 and is projected to reach USD 1.60 billion by 2030, expanding at a CAGR of 13.4% from 2025 to 2030. Market growth is primarily driven by the rising demand for advanced and efficient drug discovery technologies that can accelerate hit identification while reducing development costs and timelines. DNA-encoded library technology enables the simultaneous screening of billions of chemical compounds, significantly improving the probability of identifying viable lead candidates. Pharmaceutical and biotechnology companies are increasingly adopting DEL platforms to address the growing burden of chronic and complex diseases, including cancer, neurological disorders, and infectious diseases. Continuous advancements in molecular biology, next-generation sequencing (NGS), and automation are further strengthening the performance and scalability of DNA-encoded library platforms across research and develop...
Read more

In Vitro Fertilization Market Poised for Significant Growth Amid Rising Infertility Rates Worldwide

 The rising infertility among the male and female population across the globe is the primary driving factor for the growth of the in vitro fertilization market. Other main contributing factors to the growth of the market include rising reproductive tourism and the growing awareness among the population regarding in vitro fertilization. According to WHO, approximately 1 in 6 people(17.5% of the global population) worldwide – have infertility, which indicates a growing requirement for infertility treatments.   The change in lifestyle and increase in the average age of marrying, as well as an increase in the average age of conceiving a first child, is increasing globally. As the number of individuals opting for IVF treatments is growing, this trend is fueling the growth of in vitro fertilization treatments. In addition, many career-oriented women are opting for freezing their eggs and planning to have a child at a later stage in life. This growing reliance on fertility methods ...
Read more

Circulating Tumor Cells Market Benefits From Early Detection Technologies

The global   circulating tumor cells (CTCs) market   size was estimated at USD 12.61 billion in 2024 and is projected to reach USD 24.96 billion by 2030, expanding at a CAGR of 12.2% from 2025 to 2030. CTCs have gained significant traction in cancer diagnostics due to their noninvasive nature and enhanced diagnostic efficiency, making them a promising modality for early cancer detection and disease monitoring. Key Market Trends & Insights North America captured the largest market share of 40.91% in 2024. By technology, the CTC detection and enrichment methods segment accounted for the largest revenue share of 40.92% in 2024. By application, clinical segment dominated the market and captured the largest revenue share in 2024. By product, the kits & reagents segment dominated the market and accounted for the largest revenue share of 45.34% in 2024. By specimen, the blood segment dominated the market and accounted for the largest revenue share of 48.13% in 2024. By end-us...
Read more